ArticleInternational journal of medical informatics2025
Acceptability and perceived usefulness of the CHAMPS intervention for improving medication adherence among people with HIV in Alabama and New York.
Article in International journal of medical informatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Efficacy of CHAMPS for Improving Viral Suppression: A Randomised Clinical Trial.AIDS and behavior · 2025Trial
- Acceptability and perceived usefulness of the MyPEEPS mobile app for young transgender men.Nursing outlookArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundAntiretroviral therapy allows people with HIV to manage the disease as a chronic illness rather than a fatal diagnosis as regular adherence can lead to viral suppression. It is estimated, however, that less than two-thirds of people with HIV in the United States sustain viral suppression. Community Health Workers and mHealth to Improve Viral Suppression (CHAMPS) is useful for improving and personalizing care and may help promote medication adherence among people with HIV.
objectiveWe aimed to understand acceptability and perceived usefulness of the CHAMPS intervention.
methodsIn-depth interviews were carried out with a total of 42 intervention participants from the RCT of the CHAMPS intervention versus standard of care on ART adherence and viral suppression among PWH, which enrolled participants between May 2021 and May 2023 in the NYC and Birmingham, AL areas, to obtain feedback on the CHAMPS intervention, a combination of CHW sessions, and the CleverCap app and device. Interviews were transcribed and coded using a codebook guided by the Unified Theory of Acceptance and Use of Technology framework.
resultsParticipants ranged from 19 to 65 years old with a mean of 47 years. Most participants (62 %) identified as cisgender female, 33 % as cisgender male, 2 % as transgender male, and 2 % as transgender female. Participants believed the CleverCap app and device and CHW sessions were useful for medication adherence and, consequently, reducing viral load. Participants identified varying levels of difficulty with using the intervention, and varying levels of comfort with using the intervention in public settings. Overall, participants felt they could integrate the intervention into their daily lives and that it was instrumental in achieving improved health status and quality of life.
conclusionDespite some complexities associated with use of the intervention, participants overwhelmingly demonstrated interest in and were pleased with the CleverCap app and device and CHW sessions for improvement of viral load and overall health status. Positive feedback during the interviews supports future testing of the CHAMPS mHealth and CHW intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.